Alnylam Pharmaceuticals Inc (ALNY)
152.33
+2.02
(+1.34%)
USD |
NASDAQ |
May 03, 16:00
152.43
+0.10
(+0.07%)
After-Hours: 20:00
Alnylam Pharmaceuticals Total Assets (Quarterly): 3.824B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 3.824B |
December 31, 2023 | 3.830B |
September 30, 2023 | 3.839B |
June 30, 2023 | 3.402B |
March 31, 2023 | 3.392B |
December 31, 2022 | 3.546B |
September 30, 2022 | 3.535B |
June 30, 2022 | 3.330B |
March 31, 2022 | 3.434B |
December 31, 2021 | 3.643B |
September 30, 2021 | 3.472B |
June 30, 2021 | 3.509B |
March 31, 2021 | 3.255B |
December 31, 2020 | 3.407B |
September 30, 2020 | 3.307B |
June 30, 2020 | 3.374B |
March 31, 2020 | 2.280B |
December 31, 2019 | 2.395B |
September 30, 2019 | 2.542B |
June 30, 2019 | 2.716B |
March 31, 2019 | 2.014B |
December 31, 2018 | 1.575B |
September 30, 2018 | 1.676B |
June 30, 2018 | 1.789B |
March 31, 2018 | 1.923B |
Date | Value |
---|---|
December 31, 2017 | 1.995B |
September 30, 2017 | 1.358B |
June 30, 2017 | 1.434B |
March 31, 2017 | 1.134B |
December 31, 2016 | 1.263B |
September 30, 2016 | 1.313B |
June 30, 2016 | 1.382B |
March 31, 2016 | 1.317B |
December 31, 2015 | 1.387B |
September 30, 2015 | 1.436B |
June 30, 2015 | 1.531B |
March 31, 2015 | 1.629B |
December 31, 2014 | 1.080B |
September 30, 2014 | 986.36M |
June 30, 2014 | 1.033B |
March 31, 2014 | 1.080B |
December 31, 2013 | 420.53M |
September 30, 2013 | 447.50M |
June 30, 2013 | 462.56M |
March 31, 2013 | 471.58M |
December 31, 2012 | 287.52M |
September 30, 2012 | 322.35M |
June 30, 2012 | 318.48M |
March 31, 2012 | 340.30M |
December 31, 2011 | 281.92M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
2.280B
Minimum
Mar 2020
3.839B
Maximum
Sep 2023
3.302B
Average
3.405B
Median
Total Assets (Quarterly) Benchmarks
Ionis Pharmaceuticals Inc | 2.990B |
Pfizer Inc | 226.50B |
Blueprint Medicines Corp | 1.049B |
BridgeBio Pharma Inc | 849.33M |
Madrigal Pharmaceuticals Inc | 640.55M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 4.044B |
Shareholders Equity (Quarterly) | -219.27M |
Debt to Equity Ratio | -4.660 |
Current Ratio | 3.174 |
Net Debt Paydown Yield | -0.01% |